DIM
TECH icon

DC Investments Management’s Bio-Techne TECH Stock Holding History

DC Investments Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,544
Closed -$366K – 269
2020
Q2 		$366K Buy
+5,544
New +$332K 0.13% 113
2019
Q2 		– Sell
-14,028
Closed -$696K – 366
2019
Q1 		$696K Hold
14,028
– – 0.44% 50
2018
Q4 		$508K Hold
14,028
– – 0.41% 121
2018
Q3 		$716K Sell
14,028
-284
-2% -$12.6K 0.48% 29
2018
Q2 		$529K Sell
14,312
-1,324
-8% -$50.6K 0.34% 170
2018
Q1 		$590K Sell
15,636
-6,324
-29% -$223K 0.4% 85
2017
Q4 		$711K Buy
+21,960
New +$698K 0.29% 92

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DC Investments Management's TECH Position: Q3 2020 in Review

DC Investments Management sold out of Bio-Techne (TECH) in Q3 2020, closing a stake of 5,544 shares — an estimated $366K sold.

DC Investments Management first reported a position in TECH in Q4 2017 and held it in 7 quarters. The position peaked at $716K in Q3 2018. 418 funds tracked by Wall St. Rank hold TECH as of Q3 2020.

  • DC Investments Management reported no remaining Bio-Techne position as of Q3 2020 after selling out during the quarter.
  • DC Investments Management sold 5,544 Bio-Techne shares in Q3 2020, an estimated $366K.
  • DC Investments Management first reported a position in Bio-Techne in Q4 2017 and held it in 7 quarters.
  • DC Investments Management's Bio-Techne position peaked at $716K in Q3 2018.
  • 418 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.